Associazione La Nostra Famiglia

Ponte Lambro 8 trials 7 recruiting

8 Registered trials

7 Currently recruiting

Organisation

Associazione La Nostra Famiglia

Location

Ponte Lambro, Italy

Identifier

ORG-100010348

Address

Via Don Luigi Monza 20, 23842, Italy

Departments

-
.O.C. Riabilitazione Specialistica (funzionale/infantile post-chirurgica)
Child neuropsychiatry
Neurology
Neurorehabilitation-Unit of Rare Diseases
OC Riabilitazione Neuromotoria UGDE - URNA
Unità Operativa Psicofarmacologia e Psicoterapia dello Sviluppo
Unità per le Disabilità gravi dell’età Evolutiva e Giovane Adulta
UOC Riabilitazione Neuromotoria

Clinical trials at this site (8)

Search interface

Long Term Study of Ecopipam Tablets in Children, Adolescents and Adults with Tourette’s Disorder Recruiting

2023-503545-67-00 Tourette's Disorder 5 2024-04-30
Intranasal Cenegermin in Pediatric Participants with Spastic Cerebral Palsy. Recruiting

2025-522786-29-00 Spastic Cerebral Palsy 4 2026-01-07
A Phase 3 study of Omaveloxolone in participants with Friedreich’s Ataxia Ages 2 < 16 years Recruiting

2025-520896-13-00 Friedreich’s ataxia 5 2025-12-04
Randomised, double-blind, placebo-controlled, multicentre study to evaluate the efficacy, safety and tolerability of givinostat in non-ambul… Recruiting

2023-503521-19-00 Duchenne muscular dystrophy (DMD) 5 2024-02-09
Study in which all the patients take the same investigational drug with the aim of evaluate the long-term safety, tolerability, and efficacy… Recruiting

2023-504520-26-00 Duchenne Muscular Dystrophy (DMD) 5 2017-10-19
An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children a… Ended

2023-503678-18-00 Autism spectrum disorders 4 2023-10-10
Ecopipam Tablets to Study Tourette’s Disorder in Children, Adolescents and Adults (D1AMOND) Ended

2023-503494-38-00 Tourette’s Disorder 5 2023-07-20
A study to evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of treatment in children and adolescents with ASD Ended

2024-512202-25-00 Irritability associated with autistic disorder in child 4 2023-02-27